CIDRAP newsletters options
While Latino people have lower rates of mortality despite their higher rates of poverty compared with White people in the United States, the COVID-19 pandemic erased it, at least in Los Angeles County, according to a JAMA research letter yesterday.
Plus, mask recommendations are returning, with a pediatrics group calling for them for schoolchildren.
The antibiotic didn't lower the rate of symptoms by 14 days in non-hospitalized patients.
Elsewhere, countries in Southeast Asia report more daily record highs, and Tunisia's surge has toppled its healthcare system.
Eighty percent of survey respondents in 10 developing countries indicated a willingness to get a COVID-19 vaccine, compared with 65% in the United States and 30% in Russia, according to a study published late last week in Nature Medicine.
Residents with Alzheimer's or advanced dementia are susceptible to infections with drug-resistant microbes.
"This is becoming a pandemic of the unvaccinated," CDC head says, as indoor masking returns to LA County.
New studies highlight 203 symptoms, indicators for long COVID, and the condition's rarity in children.
Though Delta activity is growing steadily, so far severity indicators have shown little rise.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
A multicomponent intervention implemented at nursing homes in Michigan significantly reduced the prevalence of multidrug-resistant organisms (MDROs) in residents' rooms, according to the results of a randomized clinical trial reported today in JAMA Network Open.
Half of patients hospitalized with severe COVID-19 across 302 UK hospitals developed one or more health complications within 28 days or discharge, according to a study yesterday in The Lancet.
The drug was not tied to faster recovery, but the regimen might be why.
About 23 million kids missed their basic vaccines in 2020.
Misinformation has led people to avoid effective approaches, causing avoidable illnesses and death, he says.
New data presented today indicate that a shorter treatment regimen for highly drug-resistant forms of tuberculosis (TB) remains highly effective with reduced doses of one of its components.
Yesterday in the New England Journal of Medicine results from a phase 3 trial showed that a combination of bamlanivimab plus etesevimab monoclonal antibodies led to a lower incidence of COVID-19–related hospitalization and deaths.
Twelve of 20 fast food and casual eateries received an "F" for their sourcing policies.
A video tool increased patient knowledge, desire for more info, and mask acceptance.
The increases come as poll data show 1 in 4 young adults say they are not likely to get the vaccine.
Much of the increase in cases is led by the more transmissible Delta variant, which has now been detected in 111 nations.
